摘要:
Componds and pharmaceutical compositions are provided that inhibit the activity of poly ADP-ribose synthetase (PARP). Such componds are useful in the treatment of various diseases, conditions and injuries such as stroke, myocardial infarction, ischemia-perfusion injury in various organs, traumatic brain injury, atherosclerosis, inflammatory diseases and cancer.
摘要:
Compounds and pharmaceutical compositions are provided that inhibit the activity of poly ADP-ribose synthetase (PARP). Such compounds are useful in the treatment of various diseases, conditions and injuries such as stroke, myocardial infarction, ischemia-perfusion injury in various organs, traumatic brain injury, atherosclerosis, inflammatory diseases and cancer.
摘要:
Compounds and pharmaceutical compositions are provided that inhibit the activity of poly ADP-ribose synthetase (PARP). Such compounds are useful in the treatment of various diseases, conditions and injuries such as stroke, myocardial infarction, ischemia-perfusion injury in various organs, traumatic brain injury, atherosclerosis, inflammatory diseases and cancer.
摘要:
Compounds and pharmaceutical compositions are provided that inhibit the activity of poly ADP-ribose synthetase (PARP). Such compounds are useful in the treatment of various diseases, conditions and injuries such as stroke, myocardial infarction, ischemia-perfusion injury in various organs, traumatic brain injury, atherosclerosis, inflammatory diseases and cancer.
摘要:
The present invention provides compositions and formulations of compounds having formula (I) and pharmaceutically acceptable derivatives thereof, wherein p, R1, R2 and B are as described generally and in classes and subclasses herein, and additionally provides pharmaceutical compositions thereof, and methods for the use thereof for the treatment of any of a number of injuries, conditions or diseases in which HGF/SF or the activities thereof, or agonists or antagonists thereof have a therapeutically useful role. In addition, methods are provided for treating such diseases or diseases starting at a time after the onset of the injury, condition or disease.
摘要:
The present invention provides compositions and formulations of compounds having formula (I) and pharmaceutically acceptable derivatives thereof, wherein p, R1, R2 and B are as described generally and in classes and subclasses herein, and additionally provides pharmaceutical compositions thereof, and methods for the use thereof for the treatment of any of a number of injuries, conditions or diseases in which HGF/SF or the activities thereof, or agonists or antagonists thereof have a therapeutically useful role. In addition, methods are provided for treating such diseases or diseases starting at a time after the onset of the injury, condition or disease.
摘要:
Systems and methods for a battery life extender are disclosed. One disclosed system includes: a switching circuit configured to be coupled to a battery; a first voltage booster coupled to the switching circuit; a second voltage booster coupled to the switching circuit, the switching circuit configured to apply power to the first voltage booster and the second voltage booster; and a capacitor coupled to each of the first voltage booster and the second voltage booster.
摘要:
Methods, devices, and systems implementing AC mains circuit parameter characterization are provided. One example embodiment of an image forming device includes a variable electrical load, and a controller adapted to vary the electrical load based on a characterization of AC mains circuit parameters including source voltage and line impedance wherein line impedance is determined for a change in source voltage.
摘要:
Systems and methods for drilling a well bore in a subsea formation from an offshore structure positioned on a water surface with a drill string that is suspended from the structure and includes a bottom hole assembly adapted to form a top hole portion of the well bore. A drilling fluid source on the offshore structure supplies drilling fluid through the drill string to the bottom hole assembly where the drilling fluid exits from the bottom hole assembly during drilling and returns up the well bore. A suction module is disposed at the sea floor and collects the drilling fluid emerging from the well bore. A pump module is disposed on a return line, which is in fluid communication with the suction module, at a position below the water surface and above the sea floor. The pump module is operable to receive drilling fluid from the suction module and pump the drilling fluid through the return pipe to the same offshore structure or a different offshore structure.